- Home
- WWR vs RNXT Comparison
WWR vs RNXT Comparison
Compare WWR & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WWR | RNXT |
|---|---|---|
| Founded | 1977 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 36.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | WWR | RNXT |
|---|---|---|
| Price | $0.83 | $0.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $1.88 | ★ $7.75 |
| AVG Volume (30 Days) | ★ 1.9M | 188.0K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $928,000.00 |
| Revenue This Year | N/A | $2,795.35 |
| Revenue Next Year | N/A | $272.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.45 | $0.70 |
| 52 Week High | $3.75 | $1.69 |
Technical Indicators
Market Signals| Indicator | WWR | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 42.02 |
| Support Level | $0.84 | $0.89 |
| Resistance Level | $0.93 | $1.00 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.39 | 7.06 |
Price Performance
Historical ComparisonAbout WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.